Biomerica's Cash Crisis Mirrors Global Biotech Funding Crunch
California-based Biomerica faces bankruptcy as operating losses drain cash reserves, with management warning the company may not survive 12 months. The medical diagnostics firm joins dozens of undercapitalized biotech companies worldwide struggling to commercialize intellectual property amid tightening venture capital flows. Shareholders face dilution or total loss as emergency financing options narrow.
ViaNews Editorial Team•